Back to VANGUARD GROUP INC VANGUARD GROUP INC

BIIBBIIB
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in BIOGEN INC

As of its last 13F, for Q4 2025, Vanguard Group held 17,447,092 shares of BIIB (Biogen), worth $3.1B. It increased the position by 157,857 shares (+0.9%) from Q3 2025. Vanguard Group held BIIB from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$3.1B

Current Shares

17.4M

Total Value Change

-$162.4M

Total Shares Change

+768,585

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
17.4M
+0.9%
$3.1B0.0%$175.99
32
2025-Q3
Decreased
17.3M
-0.0%
$2.4B0.0%$140.08
0
2025-Q2
Increased
17.3M
+1.5%
$2.2B0.0%$125.59
32
2025-Q1
Increased
17M
+1.7%
$2.3B0.0%$136.84
32
2024-Q4
Increased
16.7M
+0.4%
$2.6B0.0%$152.92
32
2024-Q3
First report
16.7M
-
$3.2B0.1%$193.84
0

Other major holders of BIIB: PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used